- Global Pharma News & Resources

Motion Stimulation Therapy Market Size Worth US$ 1.8 Million | Exclusive Report by FMI

Motion Stimulation Therapy Market Snapshot (2022 – 2032)

Motion stimulation therapy is a type of physical therapy that is used when an event such as a stroke or spinal cord injury occurs, resulting in muscle denervation and paralysis or weakness. Motion stimulation therapy aids in the production of voluntary forces required for the joint moments, allowing for the functional performance of daily tasks.

Motion Stimulation Therapy Market Size was valued at US$ 1.1 Million in FY 2021, and is projected to grow at a 9.1% Y-o-Y growth rate until 2022, reaching a market value of US$ 1.2 Million. During the forecast period ranging from 2022 to 2032, a CAGR of 4.1% is expected for the market, reaching US$ 1.8 Million.

Motion stimulation therapy can help with muscle spasms, pain relief, and inflammation reduction. Motion stimulation therapy also encourages muscle contraction, which helps to prevent muscle atrophy. Motion stimulation therapy can help with Parkinson’s disease, a progressive neurodegenerative disorder that affects the elderly.

Report Attribute

Base Year Value (2021)

US$ 1.1 Million

Expected Market Value (2022)

US$ 1.2 Million

Anticipated Forecast Value (2032)

US$ 1.8 Million

Projected Growth Rate (2022-2032)

4.1% CAGR

Deep brain stimulation is a form of motion stimulation therapy that is used to treat Parkinson’s disease. The most common surgical treatment for Parkinson’s disease is deep brain stimulation. Advanced motion stimulation therapies, such as functional stimulation and therapeutic electric stimulation, are also widely used for better outcomes and faster recovery from muscular dysfunction. These therapies employ devices that work by electrically stimulating and contracting muscles via electric impulses.

Request a Sample Copy of this research:

Which are Some Prominent Drivers Spearheading Motion stimulation therapy Market Growth?

The primary factor driving the growth of the motion stimulation market is the increasing prevalence of Parkinson’s disease. The rising number of traffic accidents and muscle injuries is expected to fuel the growth of the motion stimulation therapy market. Motion stimulation therapy can also be used in conjunction with standard medication.

This is known as combination therapy, and the fact that motion stimulation therapy can be used as an add-on therapy is expected to drive market growth in the motion stimulation therapy market. Technological advancements in stimulator devices are also helping to drive the growth of the motion stimulation therapy market.

The global Motion Stimulation Therapy market is expected to grow significantly during the forecast period due to an increase in government funding for the development of novel drugs. According to the Parkinson’s Association of the Carolinas, nearly 60,000 people in the United States are diagnosed with Parkinson’s disease each year, with an estimated 10 million people worldwide living with the disease.

Because of the rising prevalence of Parkinson’s disease worldwide, the functional neuromuscular stimulation therapy segment is expected to gain the most market share in the global motion stimulation therapy market. Hospitals are expected to be the most dominant end-user segment due to an increase in the number of patients seeking motion stimulation therapy.

How is North America Contributing to the Growth of the Motion stimulation therapy Market?

Because of the rising incidences of musculoskeletal disorders and rising fitness awareness, the motion stimulation therapy market is expected to grow at a CAGR of 4.8 percent during the forecast period in North America. For example, the World Health Organization (WHO) reported in February 2021 that around 1.71 billion people worldwide suffer from musculoskeletal disorders.

Because of high spending on healthcare products, favorable reimbursement policies, and increased adoption among sedentary consumers, the North American region is well-positioned to reign supreme in the global muscle stimulation devices market.

Talk to our Analyst for Further Assistance:

Key Companies Profiled:
Valencia CA USA, , Cyberonics, , Medtronic, , Innovative Neurotronics Inc., , Boston Scientific Corporation, , Bioness Inc., , St. Jude Medical Inc., , Nevro Corporation

Report Scope

Growth Rate

CAGR of 4.1% from 2022 to 2032

Market Value for 2022

US$ 1.2 Million

Market Value for 2032

US$ 1.8 Million

Base Year for Estimation


Historical Data


Forecast Period


Segments Covered

  • Therapy Type
  • End User

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding China & Japan
  • China
  • Japan
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Russia
  • Poland
  • Australia & New Zealand
  • India
  • GCC
  • South Africa

Get in Touch With Our Team For 20% Flat Discount:

Market Competition

Valencia, CA, USA, Cyberonics, Medtronic, Innovative Neurotronics, Inc. Boston Scientific Corporation; Bioness Inc. St. Jude Medical; Inc., and Nevro Corporation are some of the key players found across the value chain of motion Stimulation therapy market. Because of the large number of participants, the market is extremely competitive.

Key Segments Covered in the Motion Stimulation Therapy Market Study

Motion Stimulation Therapy Market by Therapy Type:

  • Functional Neuromuscular Motion Stimulation Therapy
  • Peripheral Motion Stimulation Therapy
  • Deep Brain Motion Stimulation Therapy
  • Therapeutic Electrical Motion Stimulation Therapy

Motion Stimulation Therapy Market by End User:

  • Motion Stimulation Therapy across Hospitals
  • Motion Stimulation Therapy across Specialty Clinics
  • Motion Stimulation Therapy across Other End User

Motion Stimulation Therapy Market by Region:

  • North America Motion Stimulation Therapy Market
  • Latin America Motion Stimulation Therapy Market
  • Western Europe Motion Stimulation Therapy Market
  • Eastern Europe Motion Stimulation Therapy Market
  • Asia Pacific excluding China & Japan Motion Stimulation Therapy Market
  • China Motion Stimulation Therapy Market
  • Japan Motion Stimulation Therapy Market
  • Middle East and Africa Motion Stimulation Therapy Market

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
United Arab Emirates
For Sales Enquiries:

Editor Details

Last Updated: 30-Sep-2022